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Abstract
Background: Patients with chronic asthma have thicker intrapulmonary airways measured on high resolution
computed tomography (HRCT). We determined whether the presence of lower airway bacteria was associated with
increased airway wall thickness.
Methods: In 56 patients with stable severe asthma, sputum specimens obtained either spontaneously or after
induction with hypertonic saline were cultured for bacteria and thoracic HRCT scans obtained. Wall thickness (WT)
and area (WA) expressed as a ratio of airway diameter (D) and total area, respectively, were measured at five levels.
Results: Positive bacterial cultures were obtained in 29 patients, with H. influenzae, P. aeruginosa and S. aureus
being the commonest strains. Logistic regression analysis showed that this was associated with the duration of
asthma and the exacerbations during the past year. In airways > 2 mm, there was no significant difference in WA
(67.5 ± 5.4 vs 66.4 ± 5.4) and WT/D (21.6 ± 2.7 vs 21.3 ± 2.4) between the culture negative versus positive groups.
Similarly, in airways (≤ 2 mm), there were no significant differences in these parameters. The ratio of √wall area to
Pi was negatively correlated with FEV1% predicted (p < 0.05).
Conclusions: Bacterial colonization of the lower airways is common in patients with chronic severe asthma and is
linked to the duration of asthma and having had exacerbations in the past year, but not with an increase in airway
wall thickness.
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Background
The lower airways have until recently been considered
to be a sterile environment, and in airway diseases such
as bronchiectasis and COPD, the isolation of bacteria
such as Haemophilus influenzae and Pseudomonas spe-
cies in sputum samples by culture is not an uncommon
event [1,2]. While these pathogens are often associated
with exacerbations, they are also often present during
stable phase of the airways disease indicating chronic
colonisation. The isolation of bacterial pathogens in
chronic asthma by culture remains understudied. In one
report, 27% of asthmatic patients presenting with an
exacerbation of asthma had bacteria in sputum with
Streptococcus pneumonia, Streptococcus pyogenes,
Staphylococcus aureus, Moraxella catarrhalis and Hae-
mophilus influenzae [3]. This spectrum of bacterial spe-
cies was also isolated from induced sputum samples in
15% of patients during a stable period of asthma [4].
The more sensitive technique of 16S ribosomal RNA
microarray to detect bacterial strains in lower airway
epithelial brushings, has revealed an increase in bacterial
burden and diversity in patients with mild to moderate
asthma compared to non-asthmatic individuals [5,6].
Thus, there may be an increased propensity for asth-
matics to carry more bacterial pathogens in their lower
airways.
The role of pathogenic bacteria in the lower airways of
patients with asthma is unclear. Bacteria through the
activation of the innate immune response such as the
toll-like receptors may induce the release of inflamma-
tory cytokines such as IL-8 and TNFa that could induce
neutrophilic inflammation. Asthma is usually
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driven by many factors including Th-2 derived cytokines
and airway wall remodeling processes that results in
subepithelial fibrosis and an increase in airway smooth
muscle mass [7]. Bacterial infections may also contribute
to airway wall remodeling through the activation of
fibrosis by the release of growth factors such as TGFb,
induced by bacterial lipopolysaccharide, leading to fibro-
blast activation and release of extracellular matrix pro-
teins [8]. In addition, bacterial products may induce
goblet cell hyperplasia and glandular hypertrophy. These
changes may be reflected in an increase in airway wall
thickness detectable on a high resolution computed
tomogram. We therefore hypothesized that the presence
of pathogenic bacteria may be associated with an
increase in airway wall remodeling that would be
reflected in a greater wall thickness. Previous studies
using HRCT scans have reported an increase in airway
wall thickness in patients with asthma, with the greatest
responses seen in those with more severe disease [9-11].
We studied severe asthma patients defined as having
persistent symptoms of chronic asthma with frequent
exacerbations despite being on maximal treatment medi-
cations for their disease [12,13]. We determined the pre-
valence of pathogenic bacteria that can be cultured from
sputum samples and measured airway wall thickness
using HRCT scans.
Methods
Subjects
Patients with severe asthma were prospectively recruited
f r o mt h eS e v e r eA s t h m ac l i n i ca tt h eR o y a lB r o m p t o n
Hospital, London, over a 6-month period. Asthma was
diagnosed on the basis of chronic symptoms and/or of
recurrent exacerbations together with previously docu-
mented reversible airflow obstruction of > 15% either
spontaneously or with treatment. Asthma was consid-
ered severe because of persistent symptoms and/or
recurrent exacerbations despite the use of high dose
inhaled steroid therapy, and often in addition to needing
regular oral steroid therapy [13]. All patients had been
attending the clinic for at least 6 months and had
undergone a Severe Asthma Protocol for confirmation
of the diagnosis of severe asthma [14]. Patients with an
exacerbation of asthma within the last 4 weeks or with a
respiratory tract infection requiring antibiotic treatment
within 6 weeks were excluded. Patients with bronchiec-
tasis as judged by a high resolution computed tomo-
grams (HRCT) of the lungs were excluded. Patients
were included in the study if they provided a sample of
sputum either spontaneously or through its induction by
inhalation of hypertonic saline. This project was
approved by the Royal Brompton and NHLI Ethics
Committee and patients provided informed consent
(REC reference: 10/H0711/63).
Lung function and atopic status
FEV1 and forced vital capacity (FVC) were measured
using a spirometer (Erich Jaeger UK Ltd, Market Har-
borough, UK) and published predicted values [15]. Sin-
gle breath diffusing capacity to carbon monoxide was
measured and the transfer coefficient factor to carbon
monoxide (KCO) was calculated according to transfer
factor per unit alveolar volume. Lung volumes including
residual volume (RV), and total lung capacity (TLC)
were measured in a body plethysmograph (Master Lab;
Erich Jaeger UK Ltd).
Atopy was defined by the presence of positive skin-
prick tests to at least one common aeroallergen includ-
ing house dust mite, grass and tree pollen, cat dander
and dog dander, aspergillus, alternaria and
cladasporidium.
Sputum culture and quantitative bacterial culture
Sputum samples were first obtained by spontaneous
production. If this was not possible, the subject then
underwent a hypertonic saline challenge in order to
induce sputum production [16]. Sputum plugs were
separated from saliva using forceps. An aliquot of spu-
tum was selected using a positive displacement pipette
and used for quantitative bacteriological culture [17].
Sputum samples were plated and incubated at 37°C in
an atmosphere of 5% CO2 in air and examined for bac-
terial growth after 24 and 48 hours. The definition of a
significant load of bacteria in the study was a level
which resulted in growth to 10 × 10
6 colony-forming
units (cfu)/ml for any individual pathogenic respiratory
bacteria.
In patients in whom there was a positive bacterial
growth, one or more repeat sputum samples were sub-
sequently obtained for further bacterial culture.
High resolution computed tomographic (HRCT) scans
HRCT scans were performed on full inspiration on a
Somatom ‘Sensation’ 64-slice CT (Siemens, Erlangen,
Germany) using a volume acquisition (120 KVp, 90 mA)
with 0.6 mm collimation, a pitch of 1.4 and 1 mm axial
reconstructions. The abnormalities of intrapulmonary
bronchi (wall thickness and diameter) were obtained at
five selected levels according to a previously-published
scoring system [18], as shown in Figure 1. The images
were viewed at a window level of -500 HU and a win-
dow width of 1500 HU. Only the bronchi that were
seen as end-on slices were selected.
At each level, one or two bronchial airways were iden-
tified which appeared least ovoid and had a short-axis
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one and maximum of two bronchi were evaluated on
each side, at each level of the scan, setting the possible
range of bronchi evaluated for each patient as between
10 and 20. If there were more than two candidate
bronchi, then the two closest to the mediastinum were
chosen. With the bronchus identified, the HRCT images
were magnified and measurements made using the elec-
tronic calipers built into the picture archiving and com-
munications system (PACS Agfa IMPAX, Germany).
The measurements were done by two pulmonary radiol-
ogists who had no knowledge of the group which the
subject belonged to. A decision was reached by consen-
sus with both radiologists making the assessment
together.
We divided the bronchi into ‘large’ airways with a
luminal diameter > 2 mm and ‘small’ airways with lumi-
nal diameter ≤ 2 mm and made airway dimensions on
these airways. Wall thickness (WT), short-axis luminal
diameter (L) and internal perimeter (Pi) were measured.
The total diameter (D) of each airway, total airway area
(A0), luminal area (AL)a n dw a l la r e a( W A) were calcu-
lated respectively, using the formulae: D = L+2WT,A 0 =
π[(2WT+L)/2]
2,A L = π(L/2)
2,W A =A 0-AL and Pi = πL.
The ratio of airway wall thickness to total diameter
(WT/ Dr a t i o ) ,a n dt h ep e r c e n t a g eo fw a l la r e a( W A%)
defined as (WA/A0)*100 were used as representative of
wall thickness [18,19].
We fitted a linear relationship between Pi and √WA
for all airways measured for each subject, and calculated
√WA at Pi of 10 mm from this relationship. This
method condenses all airway thickness measurements
into a single summary measure per subject, allowing for
comparison of airway wall thickness between subjects
while accounting for different airway sizes measured
[20].
Data analysis
Results are given as mean ± SEM. Pearson Chi-square
test and Fisher’s exact test were used to compare the
data between bacteria-negative and bacteria-positive
groups where appropriate. Logistic regression analysis
was used to assess factors associated with the presence
of positive-culture bacteria. Differences were considered
significant at p < 0.05.
Results
Patient characteristics
Fifty-six patients provided sputum samples that were
adequate for analysis of bacterial growth; of these, 16
produced sputum spontaneously and 40 after saline
inhalation. Another 9 patients could not provide spu-
tum by either way and were excluded from the study.
Twenty-nine of the 56 patients had a significant load
of pathogenic bacteria in sputum and 27 did not. A
comparison of the demographics and asthma charac-
teristics between these 2 groups is shown in Table 1.
T h ed u r a t i o no fa s t h m aa n dt h et o t a ln u m b e ro f
asthma exacerbations in the past year were signifi-
cantly higher in the group with significant bacterial
load. There were no significant differences in gender,
smoking history (defined as % current and past smo-
ker), obesity (defined as BMI ≥ 30 kg/m
2), nasal dis-
ease, atopy and serum IgE. Lung function was not
different between the 2 groups, with a degree of
chronic airflow obstruction as expected for severe
asthma patients [21]. An equally high proportion of
patients in both groups (more than three quarters)
were taking oral prednisolone on a daily basis.
Bacterial strains
The bacterial strains detected in sputum from the 29
asthmatic patients included H. influenzae, P. aeruginosa,
S. aureus, methicillin-resistant S. aureus (MRSA), S.
pneumoniae, M. catarrhalis, Coliform, B. catarrhalis, A.
xylosoxidans, K.oxytoca and S. maltophilia (Figure 2). H.
influenzae was the most common pathogenic bacteria
identified followed by P. aeruginosa and S. aureus.T h e
majority had more than one bacterium cultured (16/29
patients; 55.2%) and 6/29 (20.7%) patients had more
than two.
Twenty-six of the 56 patients had their sputum sam-
ples repeated once or more than once. These were per-
formed particularly in those that had a positive bacterial
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Figure 1 Coronal reconstruction from a non-contrast high
resolution computed tomogram (CT) of the thorax with axial
sections marked (a) at the level of the top of the aortic arch,
(b) at the carina, (c) 1 cm below the carina, (d) at the level of
the midpoint of the right pulmonary vein, and (e) 2 cm above
the dome of the right hemi-diaphragm. The corresponding axial
slices are shown (a-e). Representative measurements of airway wall
(W) and diameter (D) are shown, taken from slice (e), (i) and (ii)
respectively.
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the same bacterial strains grown as in their first sputum
culture samples, 2 had the different bacterial strains and
7 had no repeat positive bacterial cultures. In the 3 of
the 27 bacteria-negative subjects, the culture remained
negative.
Airway wall thickness
The HRCT scan measurements are presented in Table 2
and Figure 3. The radiologists did not report any gross
evidence of bronchiectasis in these airways. The mean
WT/D ratio and WA% were 21.3 ± 2.4 and 66.4 ± 5.4%
in airways > 2 mm of asthmatics with positive bacterial
cultures and 21.6 ± 2.7 and 67.5 ± 5.4% for those with
asthmatics without bacteria, respectively. In airways ≤ 2
mm of asthma patients with bacteria, these measure-
ments were 28.4 ± 4.2 and 80.2 ± 6.9%, while it was
Table 1 Baseline demographic data
Parameters Asthma with postive bacteria
(n = 29)
Asthma without positive bacteria
(n = 27)
P value
Age (years) 54.1 ± 13.4 51.9 ± 123.8 NS
Gender (male) 31.0% 33.3% NS
BMI, kg/m
2 29.8 ± 6.1 28.8 ± 5.4 NS
BSA, m
2 2.0 ± 0.3 1.9 ± 0.3 NS
Obesity % 37.9% 33.3% NS
Duration of asthma (years) 32.9 ± 17.2 20.5 ± 16.0* P < 0.05
Smoking % (current and past) 34.5% 48.1% NS
Nasal diseases% 20.7% 37.0% NS
Atopy % 41.4% 44.4% NS
Oral prednisolone % 72.4% 74.0% NS
Daily prednisolone (mg.day
-1) 18.5 ± 16.1 19.1 ± 14.3 NS
Inhaled BDP dose-equivalent (mg.day
-1) 2.2 ± 1.0 2.0 ± 0.7 NS
Hospitalizations in past year (Median, IQR) 2.0 (1.3-4.8) 0.5 (0.0-3.25) NS
Exacerbations in past year (Median, IQR) 6.0 (4.3-11.5) 3.0 (2.0-5.0) P < 0.01
FEV1, l 1.8 ± 0.6 2.1 ± 1.0 NS
FEV1% predicted 65.0 ± 20.3% 73.4 ± 27.9% NS
FVC, l 3.1 ± 1.0 3.4 ± 1.2 NS
FVC% predicted 92.3 ± 19.3% 95.4 ± 18.0% NS
TLC % predicted 105.2 ± 13.9 111.9 ± 8.2 NS
RV % predicted 132.6 ± 32.4 148.9 ± 41.0 NS
RV/TLC % 43.6 ± 9.5 45.0 ± 10.3 NS
KCO % predicted 92.1 ± 14.6 92.4 ± 12.0 NS
Blood eosinophil count (10
9/L) 0.3 ± 0.3 0.2 ± 0.2 NS
Serum IgE, IU/ml 118.0 (23.2-400.8) 149.5 (29.8-304.8) NS
Serum IgG, g/L 9.3 ± 3.4 9.5 ± 2.7 NS
Serum IgA, g/L 2.3 ± 0.9 2.3 ± 0.8 NS
Serum IgM, g/L 1.1 ± 0.5 1.2 ± 0.5 NS
Data are presented as mean ± SEM or median (interquartile range)
Obesity was defined as a BMI of ≥ 30 kg/m
2
BDP = Beclomethasone dipropionate; BMI = Body mass index; BSA = Body surface area; FEV1 = Forced expiratory volume in one second; FVC = Forced vital
capacity; TLC = Total lung capacity; RV = Residual volume; KCO = Transfer coefficient to carbon monoxide
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Figure 2 Prevalence of bacterial strains detected in sputum by
routine bacteriological culture in severe asthma patients.
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Page 4 of 827.3 ± 3.7 and 78.7 ± 6.6% in asthmatics without bac-
teria. There were no significant differences between the
groups. In addition, √WA at Pi of 10 mm was not differ-
ent between the two groups (Figure 3).
When the 56 severe asthmatic subjects were analyzed
together, √WA at Pi of 10 mm showed no correlation
with FEV1% predicted, while the ratio of √WA/Pi was
negatively correlated with FEV1% predicted (r = -0.34, p
< 0.05, Figure 4).
Factors associated with significant bacterial culture
Table 3 shows the cut-off values of variables for positive
bacterial culture in sputum of severe asthmatic patients
using logistic regression analysis. Univariate logistic ana-
lysis showed a significant association of the presence of
bacteria on sputum culture with the duration of asthma
and the number of exacerbations during the past year.
Multivariate logistic analysis revealed both duration of
asthma and the number of exacerbations in past year
contribute to significant bacterial load in sputum, when
odds ratio were adjusted for age, gender, smoking and
FEV1 (% predicted).
Table 2 Airway measurements of HRCT scans in severe asthmatics with bacteria and without bacteria
Asthma with positive bacteria Asthma without positive bacteria*
(n = 29) (n = 27)
Total bronchi examined per group 401 349
Large airways > 2 mm
Bronchi evaluated per patient 9.0 ± 3.7 9.2 ± 4.5
WT/D (%) 21.3 ± 2.4 21.6 ± 2.7
WA (%) 66.4 ± 5.4 67.5 ± 5.4
Small airways ≤ 2m m
Bronchi evaluated per patient 4.9 ± 3.3 3.9 ± 2.8
WT/D (%) 28.4 ± 4.2 27.3 ± 3.7
WA (%) 80.2 ± 6.9 78.7 ± 6.6
All airways
√WA at Pi of 10 mm 3.92 ± 0.09 4.00 ± 0.07
Data are presented as mean ± SEM
D = outer diameter; Pi = airway internal perimeter; WT = wall thickness; WA = wall area; WA% = percentage wall area
*There were no significant differences between the groups for any of these parameters
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Figure 3 Comparison airway dimensions of airways from
severe asthma patients with or without bacteria cultured in
sputum as assessed by √WA at Pi of 10 mm. There were no
significant differences between the groups. The horizontal bars
show the mean.
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Figure 4 Relationship between the ratio of √wall area to
airway internal perimeter (Pi) and FEV1% predicted in severe
asthmatics for all the airways measured (r = -0.27, p < 0.05).
The line of identity together with the 95% CI is shown.
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We found a high prevalence of bacterial colonization by
potentially pathogenic microorganisms in patients with
chronic severe asthma who were in a relatively stable
condition and who did not suffer from bronchiectasis.
Using sputum culture for bacterial detection, we found
that 52% showed positive sputum cultures with predo-
minantly H influenzae, P aeruginosa, S aureus and S
pneumoniae strains. These bacterial strains are similar
to those previously reported in other airway conditions
associated with bacterial colonization such as bronchiec-
tasis and COPD [22,23], but higher than in a group of
mild-to-moderate asthmatics or in asthmatics during an
exacerbation [3,4]. There were no overt differences
between the positive bacterial and negative bacterial
growth patients in terms of most parameters related to
severe asthma, apart from a significantly longer duration
of asthma and greater number of exacerbations in the
past year in patients with bacterial colonization. Logistic
regression analysis showed that the longer duration of
asthma and the number of exacerbations in the past
year were significant risk factors for bacterial coloniza-
tion. In a previous study of patients with severe asthma,
we found that patients with severe asthma who had sig-
nificant airflow obstruction reported a longer duration
of asthma than those with normal lung function,
together with greater evidence of airway wall thickening
measured on HRCT scan [21].
Patients with severe asthma, as well as patients with
moderate to severe COPD, are more vulnerable to
exacerbations, which have been associated with respira-
tory pathogens, particularly viruses such as rhinovirus
[24]. However, atypical bacterial infections such as
Mycoplasma pneumonia have also been associated with
exacerbations [25]. One study reported that 27% of
patients with an exacerbation of asthma had evidence of
bacterial growth in sputum [3]. However, since sputum
of asthmatics who are not experiencing an exacerbation
of their condition also show evidence of bacterial growth
in a similar or even higher prevalence [4], one could
question the relevance of these bacteria in the pathogen-
esis of these exacerbations. Interestingly, in many of the
asthmatic patients who had a positive sputum culture
also showed similar bacterial profile on repeat culture,
indicating that these bacteria were most likely colonizing
the lower airways.
In our univariate analysis, we found that a history of
previous exacerbations to be a significant risk factor for
positive bacterial cultures in sputum. The importance of
these bacteria in the lower airways of asthmatic patients,
particularly severe asthma, is currently unclear. This is
likely related to a lack of information regarding the bac-
terial flora of the lower airways of patients with severe
asthma and its variation with time or during worsening
of asthma control. Two recent studies using a sensitive
technique for determining the microbiome of the lower
airways by 16S ribosomal RNA profiling have shown
that there are bacterial species even in the lower airways
of normal individuals and that this microbiome was sig-
nificantly different in adult patients with asthma with
evidence for pathogenic Proteobacteria, particularly Hae-
mophilus spp [5,6].
An increase in airway wall thickness in asthma mea-
sured on HRCT scan has been related to the severity of
asthma and to the degree of airflow obstruction
[11,26-28]. A significant increase in airway wall thick-
ness and size has been demonstrated in severe asthma
compared to non-severe asthma and to non-asthmatic
controls [9]. This study reports similar values of wall
thickness expressed as WT/D ratio and WA%a st h o s e
measured in our study. The increases in airway wall
thickness measured on HRCT scans have been corre-
lated with airway epithelial thickness measured on fixed
tissue sections of airway biopsies, supporting the notion
that these radiological abnormalities reflected airway
wall remodeling processes [9]. On the other hand, the
thickness of the reticular basement membrane has been
Table 3 Univariate and multivariate analyses of
predictive factors for positive bacterial load
Univariate analysis
Predicting factors Odds ratio 95% CI P-
value
Age 1.012 0.971-
1.055
NS
Gender 1.111 0.362-
3.413
NS
Duration of asthma 1.046 1.005-
1.089
0.029
Exacerbations in past
year
1.258 1.024-
1.544
0.029
Smoking 1.764 0.602-
5.171
NS
FEV1 (% pred) 0.983 0.962-
1.005
NS
√WA at Pi of 10 mm 0.627 0.175-
2.248
NS
Multivariate analysis
Predicting factors Odds
ratio
Adjusted
Odds
ratio*
95% CI P-
value
Duration of asthma 1.046 1.058 1.004-
1.116
0.035
Exacerbations in past
year
1.258 1.630 1.132-
2.347
0.009
√WA at Pi of 10 mm 0.627 0.631 0.168-
2.372
NS
*Adjusted by age, gender, smoking and FEV1 (% predicted)
CI = confidence interval, NS = non-significant, Pi = airway internal perimeter
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radiologically in a mild-moderate group of asthma
patients [29]. However, our studies reveal that the pre-
sence of bacteria in sputum is not associated with an
increase in airway wall thi c k n e s sa sm e a s u r e db yt w o
indices: WT/D and WA% at 2 airway sizes of or < 2 mm
diameter. This lack of difference in airway wall thickness
is unlikely to be influenced by studying different sizes of
airways between the two groups since there was no dif-
ference in the √wall area (WA)a ta na i r w a yi n t e r n a l
perimeter (Pi) of 10 mm, which represents a composite
measure that takes into account the ranges of airway
sizes measured for each subject [20]. Interestingly, we
found a weak inverse correlation between the ratio of
√wall area (WA)t oP i with FEV1% predicted, but not
between airway wall thickness or √wall area (WA)a ta n
airway internal perimeter (Pi)o f1 0m mw i t hF E V 1%
predicted, as previously reported [11,29].
Our data on the persistence of these bacteria in spu-
tum shows that a high proportion of the positive spu-
tum were also positive on repeat sputum testing with
the same bacterial species, ie 14 out of 23 patients.
However, in the other 9, there was either a different
bacteria isolated or no bacteria was found. Further regu-
lar assessment is needed to determine whether these
bacteria may be considered as colonizing the lower air-
ways of patients with severe asthma. There may be var-
ious reasons why patients with severe asthma may be
predisposed to greater bacterial colonization of their
lower airways. Innate immune responses may be defec-
tive particularly in severe asthma. Toll-like receptor 4
gene expression is significantly decreased in airway neu-
trophils from asthmatics compared to healthy volun-
teers, together with the release of inflammatory
cytokines [30]. Alveolar macrophages from patients with
severe asthma compared to non-severe asthma were less
able to phagocytose bacteria or apoptotic cells [31,32].
In addition, the Th2-polarised response may itself have
a negative impact on the innate immune host response
to bacterial infections [33,34]. The potential effect of
chronic oral corticosteroid therapy, which up to 78% of
our patients were taking, may suppress innate and
acquired immune responses to bacterial infections [35].
The recent studies demonstrating an increased risk of
asthma patients developing invasive pneumococcal dis-
ease or pneumonia [36,37] is likely to be a reflection of
reduced innate immune responses in asthma, although
the exact abnormality remains to be defined.
Conclusions
Bacterial colonization of the lower airways is a common
occurrence in patients with chronic stable severe
asthma, but this was not related to the degree of airway
wall thickness measured radiologically. We therefore
conclude that bacterial colonization of asthmatic airways
may not be the primary driver of airway wall remodel-
ing, but it could be involved in other asthmatic
processes.
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